Skip to content
Screener

Karyopharm Therapeutics KPTI Q2 2026 earnings

Reported August 13, 2026 · Before market open

Revenue$33.4MBeat by $1.2M
EPS-$2.32Miss by $0.95
Revenue estimate$32.2M
EPS estimate-$1.37

Next report

Nov 2, 2026 (in a month)
Revenue estimate$33.5M
EPS estimate-$1.16

FAQ

When did Karyopharm Therapeutics report Q2 2026 earnings?
Karyopharm Therapeutics (KPTI) reported Q2 2026 earnings on August 13, 2026 before market open.
What were Karyopharm Therapeutics's Q2 2026 revenue and EPS?
Karyopharm Therapeutics reported revenue of $33.4M and eps of $-2.32 for Q2 2026.
Did Karyopharm Therapeutics beat estimates in Q2 2026?
Revenue beat the consensus estimate of $32.2M by $1.2M. EPS missed the consensus estimate of $-1.37 by $0.95.
How did Karyopharm Therapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 11.9% from $37.9M a year earlier and eps grew 46.3% from $-4.32.
Where can I find Karyopharm Therapeutics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-347897) and the 10-Q periodic report (0001193125-26-347906) directly on SEC EDGAR. The filing index links above go to sec.gov.